Veregen ointment for actinic keratosis on face or scalp
Part of Cancer, Skin clinical trials.
This study tests a herbal ointment (Veregen) for actinic keratosis, a common precancerous skin condition. The ointment is applied to the face or bald scalp. It may offer a new treatment option for mild to moderate spots.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have between 4 and 8 mild to moderate actinic keratosis spots on your face (excluding eyelids, lips, and inside the mouth) or on your bald scalp, all within an area about 5 inches by 5 inches.
- You have not used certain skin treatments (like cryotherapy, topical chemotherapy, or photodynamic therapy) in that area for at least 4 to 12 weeks, depending on the treatment.
- You are not pregnant or breastfeeding, and if you could become pregnant, you agree to use highly effective birth control during the study and for 4 weeks after.
- You can avoid sunbathing, tanning beds, and intense sun exposure in the treatment area during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two different creams used before a light-based treatment (photodynamic therapy) for actinic keratoses on the scalp. It aims to see which pre-treatment works better to clear these rough, scaly spots.
This trial tests an ointment called HW211026 for people with actinic keratosis, a common skin condition caused by sun damage. The study will check if the ointment is safe and works when applied to a 10 cm by 10 cm area on the face.
This trial tests how a new drug works in people with actinic keratosis (rough, scaly patches caused by sun damage) on their upper arms or face. You will receive the treatment and have blood samples taken to see how your body processes the medication.
This study tests whether tirbanibulin (Klisyri) cream works well on specific types of actinic keratosis on the scalp or face that have a downward growth pattern. It helps doctors understand if this treatment is right for those skin spots.
This trial tests a reformulated light-activated cream (Levulan Kerastick) for treating actinic keratosis (precancerous skin spots) on the face or bald scalp. It is a phase 3 study to see if the new version works better with fewer side effects.
This trial tests an investigational gel called HW211026 for people with actinic keratosis, a common precancerous skin condition. It aims to see if the gel is a safe and effective treatment for lesions on the face.
Hear when a new Actinic Keratosis of Face and Scalp trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.